Pan-American Center for Oncology Trials

San Juan 902

3 studies enrolling now · 6 studies all time

What they study most

Advanced Cancer, Bladder Cancer, Colorectal Cancer, Esophageal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Mature B-cell Malignancies, Metastatic Cancer, Non-Small Cell Lung Cancer (NSCLC), PDAC

Studies at this site

• Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors — Recruiting now
• Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer — Recruiting now
• Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies — Recruiting now
• Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) — Running, not enrolling
• CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung — Running, not enrolling
• DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) — Completed